Telehealth coaching and navigation by community health workers for adults with very high blood pressure
Official title: CONNECT-HTN Trial - Coaching and Navigation by CHWs Through Telehealth for High-risk Hypertension
Run by Weill Medical College of Cornell University · NCT07461415 · Data updated 2026-11-12
This trial will test whether phone-based coaching and help from community health workers can lower the risk of major heart and blood vessel problems for adults who come to the emergency department with very high blood pressure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3620 (estimated) |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 5 sites (Karachi, Sindh and 4 other locations) |
| Status | Recruiting |
| Started | March 16, 2026 |
| Main results expected | August 2029 |
| Study ends | August 2029 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT07461415 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who present to participating Karachi EDs with repeat systolic BP >180 mmHg or diastolic BP >110 mmHg without acute end-organ damage and who can receive phone contact are ideal candidates.
✕Probably not a fit
Pregnant patients, terminally ill patients, those requiring hospital admission for complications, and people who cannot be reached by phone are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial in Karachi randomly assigns adults who present to participating emergency departments with severe hypertension to either usual referral to primary care or to structured telephone-based navigation and behavioral coaching delivered by trained community health workers. The primary outcome is the rate of major adverse cardiovascular events over follow-up, with secondary outcomes including changes in blood pressure and outpatient follow-up patterns. Outcome assessments are performed by an independent team blinded to treatment assignment. The intervention is designed to be compatible with basic phones and to be scalable for low-resource urban settings.
Why it matters
Potential benefit: If successful, the intervention could lower rates of heart attacks, strokes, and other major cardiac events by improving blood pressure control and outpatient follow-up.
How similar studies have gone: Previous programs using community health workers and telehealth have improved follow-up and blood pressure control in some settings, but evidence that this approach reduces major cardiovascular events in an ED-to-primary-care pathway is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Eligible patients * Must be over the age of 18 years * Have an ED triage SBP ≥ 180 and/or DBP ≥ 110, with a repeat similar reading ≥30 minutes after triage * May have received treatment for elevated BP, but must have no evidence of end-organ damage (defined as dialysis dependence, acute stroke, acute coronary syndrome, acute kidney injury, or papilledema) * Have a functional status of either fully active (independent in daily activities) or mildly restricted but ambulatory and able to work (washing, toileting, dressing, feeding, mobility). * May be admitted for deranged BP only with no complications, or may be stable for discharge per treating emergency physician * Include referrals from the clinic to the ED with SBP/DBP values in the inclusion range * Can provide informed consent. Intervention is accessible to individuals of all literacy levels * Can receive phone calls and in-person visits. Smartphone ownership not required (intervention compatible with analog phones) Exclusion Criteria: Given that hypertension is defined and treated differently, we will exclude * pregnant patients * terminally ill patients, as well as * those requiring admission to the hospital due to severe complications (other than deranged BP).
Where it's running
-
Aga Khan University Hospital (AKUH)
Karachi, Sindh, Pakistan Recruiting -
Jinnah Postgraduate Medical Center (JPMC)
Karachi, Pakistan Recruiting -
Kharadar General Hospital (KGH)
Karachi, Pakistan Recruiting -
Sindh Institute of Emergency and Health Sciences (SIEHS)
Karachi, Pakistan Recruiting -
Dow University Hospital, Ojha Campus
Karachi, Sindh, Pakistan Withdrawn
Study contacts
- Principal investigator: Junaid Razzak, MD PhD FACEP — Weill Medical College of Cornell University
- Study coordinator: Junaid A Razzak, MD PhD FACEP
- Email: jur9123@med.cornell.edu
- Phone: +1 4437229239
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.